Elanthenral Sigamani
Overview
Explore the profile of Elanthenral Sigamani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Afshan H, Daniel M, Raj A, Singh P, Sigamani E
Indian J Pathol Microbiol
. 2024 Aug;
PMID: 39133250
Background: Nipple adenoma (NA) is a rare benign neoplasm of the nipple arising from the lactiferous duct. Often seen in middle aged women, presenting as a nodule, erosive, or ulcerative...
2.
Loya R, Abraham A, Sigamani E, Devasia A, Zachariah U, Eapen C, et al.
Indian J Gastroenterol
. 2024 Apr;
PMID: 38676909
No abstract available.
3.
Singh A, Georgy J, Dhananjayan S, Sigamani E, John A, Joel A, et al.
Gene
. 2023 Nov;
895:147980.
PMID: 37951371
Triple-negative breast cancer (TNBC) is a heterogeneous disease with poor survival compared to other subtypes. Patients with residual disease after neoadjuvant chemotherapy (NAC) face an increased risk of relapse and...
4.
Singh A, Georgy J, Joel A, Thumaty D, John A, Ramnath N, et al.
Cancer Invest
. 2023 Nov;
41(9):789-802.
PMID: 37909664
We assessed the efficacy, tolerability, and cost-effectiveness of a novel neoadjuvant regimen comprising docetaxel-cyclophosphamide alternating with epirubicin-cisplatin (ddDCEP) administered biweekly for 16 weeks in 116 patients with early triple-negative breast...
5.
Maddali M, Venkatraman A, Kulkarni U, Mani S, Raj S, Sigamani E, et al.
Ann Hematol
. 2022 Jul;
101(9):1987-2000.
PMID: 35840818
The role of next-generation sequencing (NGS) in identifying mutations in the driver, epigenetic regulator, RNA splicing, and signaling pathway genes in myeloproliferative neoplasms (MPNs) has contributed substantially to our understanding...
6.
Chandramohan J, Ganapule G, Sigamani E, George B, Korula A, Manipadam M
Indian J Pathol Microbiol
. 2022 Apr;
65(2):381-386.
PMID: 35435375
Background And Aim: Anaplastic lymphoma kinase (ALK)-positive large B-cell lymphomas (ALK-LBCLs) are aggressive CD20-negative lymphomas, accounting for <1% of diffuse LBCLs. Being rare and with peculiar immunophenotypic characteristics, these can...
7.
Masih D, Chandramohan J, Sigamani E, Fouzia N, Korula A, Simon E, et al.
Indian J Pathol Microbiol
. 2022 Jan;
65(1):137-141.
PMID: 35074979
Primary follicular lymphoma of the gut (PFL-GI) is a rare entity. This study aims to compare the clinicopathologic features of PFL-GI with cases of gastrointestinal involvement by disseminated nodal follicular...
8.
Joel A, Georgy J, Thumaty D, John A, Chacko R, Rebekah G, et al.
Ecancermedicalscience
. 2021 Apr;
15:1207.
PMID: 33912232
Background: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer is associated with poor prognosis and access to anti-HER2 treatment is still a challenge in lower-middle income countries. The availability...
9.
Kurian M, Jebasingh F, Sigamani E, Thomas N
BMJ Case Rep
. 2020 Sep;
13(9).
PMID: 32913070
No abstract available.
10.
Chanda R, Kandagaddala M, Moses V, Sigamani E, Keshava S, Janakiraman R
J Clin Imaging Sci
. 2020 May;
10:18.
PMID: 32363080
Objective: The purpose of this study was to evaluate the diagnostic performance of acoustic radiation force impulse (ARFI) imaging in differentiating benign from malignant peripheral lymphadenopathy. Materials And Methods: This...